Daniel Kaschta

🔬 Scientist | PhD candidate in Biochemistry & Molecular Biology | 🧬 Genomics & Rare Diseases | Researcher @UKSH Kiel
Now @danielkaschta.bsky.social

[Malte Spielmann @malte_spielmann]

One week left to apply! Don’t miss out on some awesome rare disease genomics in Hinxton

[Daniel Kaschta @DanielKaschta]

Preprint to our full study here: https://t.co/Ij0tnhcnuX
Let’s transform rare disease diagnosis with genome sequencing. Join the conversation below or reach out for collaboration! 🧵👇 #RareDiseases #Genomics
With @malte_spielmann and @NagelInga

[Daniel Kaschta @DanielKaschta]

Howdo genome sequencing strategies stack up for diagnosing rare diseases? In our preprint we compare GS and standard-of-care approaches in 448 cases. The results could transform your rare disease diagnostics! 🧬 #RareDiseases #Genomics 🧵👇

[Daniel Kaschta @DanielKaschta]

✅ Trio sequencing is the most comprehensive but costly.
✅ Singleton sequencing cost-effective alternative.
✅ Genome sequencing is poised to replace traditional methods as the gold standard. #InnovationInHealthcare

[Daniel Kaschta @DanielKaschta]

Preprint to our full study here: https://t.co/Ij0tnhcnuX
Let’s transform rare disease diagnosis with genome sequencing. Join the conversation below or reach out for collaboration! 🧵👇 #RareDiseases #Genomics
With @malte_spielmann and @NagelInga

[Daniel Kaschta @DanielKaschta]

Rare diseases affect millions. At UKSH @UKSH_KI_HL , Germany's second-largest hospital, we hosted a direct face-off between standard-of-care methods, singleton genome sequencing, and trio genome sequencing in real-world clinical settings. #PrecisionMedicine #RareDiseases

[Daniel Kaschta @DanielKaschta]

✅ Trio sequencing is the most comprehensive but costly.
✅ Singleton sequencing cost-effective alternative.
✅ Genome sequencing is poised to replace traditional methods as the gold standard. #InnovationInHealthcare

[Daniel Kaschta @DanielKaschta]

How do genome sequencing strategies stack up for diagnosing rare diseases? In our preprint we compare GS and standard-of-care approaches in 448 cases. The results could transform your rare disease diagnostics! 🧬 #RareDiseases #Genomics 🧵👇

[Fabian Theis @fabian_theis]

DeepSeek isn’t just fun to use (thanks @ollama) - it’s also shaking up science, since it lets us see inside. More @Nature https://t.co/3zf9EJGTmE

[Daniel Kaschta @DanielKaschta]

@malte_spielmann @HenckJana @MPI_MolGen @UKSH_KI_HL Well deserved! Congratulations 🎉

[Malte Spielmann @malte_spielmann]

Human genetics @UKSH_KI_HL retreat 2023! Tobias Haack from @uni_tue giving keynote on long read sequencing in the clinic.